{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:01:04Z","timestamp":1790625664736,"version":"4.1.0"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T00:00:00Z","timestamp":1727395200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Recent years have seen a rapid growth in the number of online health communities targeted at patients with long-term conditions. Myasthenia Gravis (MG) is a rare neurological disease for which such communities have not been analysed before. The aim of this study was to better understand the needs of the MG population through the collation and categorisation of questions that users of MG social media were asking fellow users on these platforms.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methodology<\/jats:title><jats:p>Systematic observation of four MG Facebook groups was conducted over a 2-month period. Groups were selected for analysis based on the following systematic criteria: Language (English), Membership (\u2265 5,000 members), group activity (\u2265 2 posts per week), target audience (general MG population) and researcher engagement with group administrators. The study protocol was reviewed by the institutional review board of the Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin (EA2\/106\/22). During the observation period, data were extracted from individual posts featuring questions made across each group using a systematic and objective coding scheme. All data points were coded directly from the source and collated into an SPSS database (IBM SPSS V.27, SPSS). Absolute and relative frequencies were calculated for categorical variables and proportions were compared across groups to validate the credibility and relevance of different requests.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of the 2,062 posts observed (<jats:italic>N<\/jats:italic>\u2009=\u20092,062), 1,392 featured questions (<jats:italic>n<\/jats:italic>\u2009=\u20091,392). Questions were asked by 787 unique users: 531 were identified as one-time users (67%) and 256 were identified as repeat users (33%). Six hundred and fifty six users were classified as presumed diagnosed (83%), 61 as seeking diagnosis (8%), 69 as family and\/or friends (9%) and as other (&amp;lt;0%). Eight unique categories of questions were observed including MG treatment (31%), Symptoms (19%), Living with MG (12%), Diagnosis (10%), non-MG medication (11%), Tests (8%), Location (4%) and Other (4%).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Members of the MG population make active use of online health communities to seek and discuss practical information concerning various aspects of the disease, its diagnosis and care. The openness and willingness of the sample population to share sensitive medical information shows a high need for information not entirely catered to by the medical profession.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fneur.2024.1474347","type":"journal-article","created":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T15:50:32Z","timestamp":1727452232000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Myasthenia Gravis: utilising cross-platform quantitative content analysis to uncover and validate unmet needs"],"prefix":"10.3389","volume":"15","author":[{"given":"David","family":"Legg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Meisel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maike","family":"Stein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lea","family":"Gerischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meret","family":"Herdick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Kr\u00fcger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Mergenthaler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Masanneck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Lehnerer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,9,27]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.3390\/jcm10112235","article-title":"Myasthenia gravis: epidemiology, pathophysiology and clinical manifestations","volume":"10","author":"Dresser","year":"2021","journal-title":"J Clin Med"},{"key":"ref2","year":"2023"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"111793","DOI":"10.1016\/j.mad.2023.111793","article-title":"Sex differences in neuromuscular disorders","volume":"211","author":"Vinciguerra","year":"2023","journal-title":"Mech Ageing Dev"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.3390\/brainsci13091286","article-title":"Diagnosis and management of seronegative myasthenia gravis: lights and shadows","volume":"13","author":"Vinciguerra","year":"2023","journal-title":"Brain Sci"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.ymgme.2008.10.003","article-title":"Clinical research for rare disease: opportunities, challenges, and solutions","volume":"96","author":"Griggs","year":"2009","journal-title":"Mol Genet Metab"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"205520762311529","DOI":"10.1177\/20552076231152989","article-title":"Driving time-based identification of gaps in specialised care coverage: an example of neuroinflammatory diseases in Germany","volume":"9","author":"Masanneck","year":"2023","journal-title":"Digit Health"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/j.chest.2017.12.018","article-title":"The challenge of rare diseases","volume":"153","author":"Stoller","year":"2018","journal-title":"Chest"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1177\/1355819615602725","article-title":"The PRISMS taxonomy of self-management support: derivation of a novel taxonomy and initial testing of its utility","volume":"21","author":"Pearce","year":"2016","journal-title":"J Health Serv Res Policy"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/978-3-319-73585-6_18","article-title":"Predictors of psychological health in myasthenia gravis","author":"Paul","year":"2018","journal-title":"Myasth Gravis Disord"},{"key":"ref10","first-page":"49","article-title":"Peer support for chronic medical conditions","volume-title":"Peer Support in Medicine: A Quick Guide","author":"Evans","year":"2021"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/j.ekir.2021.02.030","article-title":"Identifying information needs of patients with IgA nephropathy using an innovative social media\u2013stepped analytical approach","volume":"6","author":"Vasilica","year":"2021","journal-title":"Kidney Int Rep"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1002\/jgc4.1438","article-title":"\u201cDoctors can read about it, they can know about it, but they've never lived with it\u201d: how parents use social media throughout the diagnostic odyssey","volume":"30","author":"Deuitch","year":"2021","journal-title":"J Genet Couns"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1247931","DOI":"10.3389\/fpubh.2023.1247931","article-title":"The economic burden of individuals living with generalized myasthenia gravis and facing social determinants of health challenges","volume":"11","author":"Hughes","year":"2023","journal-title":"Front Public Health"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"e13544","DOI":"10.2196\/13544","article-title":"Using Facebook for qualitative research: a brief primer","volume":"21","author":"Franz","year":"2019","journal-title":"J Med Internet Res"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"e16337","DOI":"10.2196\/16337","article-title":"Social medical capital: how patients and caregivers can benefit from online social interactions","volume":"22","author":"Panzarasa","year":"2020","journal-title":"J Med Internet Res"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1179\/1753807612Y.0000000026","article-title":"Rare disease-specific social media sites: an opportunity for collaboration","volume":"6","author":"Walker","year":"2013","journal-title":"J Commun Healthc"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s13023-016-0532-x","article-title":"Insights into rare diseases from social media surveys","volume":"11","author":"Davies","year":"2016","journal-title":"Orphanet J Rare Dis"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"e1345","DOI":"10.1542\/peds.2013-2966","article-title":"Social media methods for studying rare diseases","volume":"133","author":"Schumacher","year":"2014","journal-title":"Pediatrics"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.3390\/ijerph15091877","article-title":"Mining facebook data of people with rare diseases: a content-based and temporal analysis","volume":"15","author":"Subirats","year":"2018","journal-title":"Int J Environ Res Public Health"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"e1083145","DOI":"10.1080\/21675511.2015.1083145","article-title":"Rare disease diagnosis: a review of web search, social media and large-scale data-mining approaches","volume":"3","author":"Svenstrup","year":"2015","journal-title":"Rare Dis"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.1038\/s41436-021-01273-z","article-title":"Opportunities and pitfalls of social media research in rare genetic diseases: a systematic review","volume":"23","author":"Miller","year":"2021","journal-title":"Genet Med"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"e020133","DOI":"10.1136\/bmjopen-2017-020133","article-title":"Online stroke forum as source of data for qualitative research: insights from a comparison with patients\u2019 interviews","volume":"8","author":"Jamison","year":"2018","journal-title":"BMJ Open"},{"key":"ref23","author":"Heise","year":"2019"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1089\/big.2018.0176","article-title":"Adjusting to the GDPR: the impact on data scientists and behavioral researchers","volume":"7","author":"Greene","year":"2019","journal-title":"Big Data"},{"key":"ref25","year":"2023"},{"key":"ref26","year":"2023"},{"key":"ref27","year":"2021"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1186\/s12883-022-02981-y","article-title":"Myasthenia gravis-a retrospective analysis of e-mail inquiries made to a patient organisation and specialized center to uncover unmet needs from patients and caregivers","volume":"22","author":"Stein","year":"2022","journal-title":"BMC Neurol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1016\/j.ekir.2021.03.890","article-title":"Facebook groups can provide support for patients with rare diseases and reveal truths about the secret lives of patients","volume":"6","author":"Gaddy","year":"2021","journal-title":"Kidney Int Rep"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"e21694","DOI":"10.2196\/21694","article-title":"Facebook support groups for rare pediatric diseases: quantitative analysis","volume":"3","author":"Titgemeyer","year":"2020","journal-title":"JMIR Pediatr Parent"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1159\/000506310","article-title":"Employment in myasthenia gravis: a systematic literature review and meta-analysis","volume":"54","author":"Guastafierro","year":"2020","journal-title":"Neuroepidemiology"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"4377","DOI":"10.1007\/s12325-023-02604-z","article-title":"People diagnosed with myasthenia gravis have lower health-related quality of life and need more medical and caregiver help in comparison to the general population: analysis of two observational studies","volume":"40","author":"Dewilde","year":"2023","journal-title":"Adv Ther"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"19275","DOI":"10.1038\/s41598-022-22078-3","article-title":"Mental health in myasthenia gravis patients and its impact on caregiver burden","volume":"12","author":"Marbin","year":"2022","journal-title":"Sci Rep"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1214041","DOI":"10.3389\/fneur.2023.1214041","article-title":"Diagnosis and therapy of myasthenia gravis\u2014the patients\u2019 perspective: a cross-sectional study","volume":"14","author":"Sobierajski","year":"2023","journal-title":"Front Neurol"},{"key":"ref35","doi-asserted-by":"crossref","DOI":"10.5772\/intechopen.99486","article-title":"Introductory chapter: rare diseases-ending the diagnostic odyssey and beginning the therapeutic odyssey","volume-title":"Rare Diseases-Diagnostic and Therapeutic Odyssey","author":"Valarmathi","year":"2021"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.ncl.2018.01.011","article-title":"Treatment of myasthenia gravis","volume":"36","author":"Farmakidis","year":"2018","journal-title":"Neurol Clin"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13023-022-02358-x","article-title":"The diagnostic odyssey: insights from parents of children living with an undiagnosed condition","volume":"17","author":"Bauskis","year":"2022","journal-title":"Orphanet J Rare Dis"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.1080\/09638288.2022.2094481","article-title":"Fragmented care and missed opportunities: the experiences of adults with myasthenia gravis in accessing and receiving allied health care in Australia","volume":"45","author":"Devlin","year":"2023","journal-title":"Disabil Rehabil"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1111\/ene.14153","article-title":"Serious infections in patients with myasthenia gravis: population-based cohort study","volume":"27","author":"Kassardjian","year":"2020","journal-title":"Eur J Neurol"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"213","DOI":"10.5582\/irdr.2018.01085","article-title":"A compilation of national plans, policies and government actions for rare diseases in 23 countries","volume":"7","author":"Khosla","year":"2018","journal-title":"Intract Rare Dis Res"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2024.1474347\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T12:45:33Z","timestamp":1727959533000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2024.1474347\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,27]]},"references-count":40,"alternative-id":["10.3389\/fneur.2024.1474347"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2024.1474347","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,27]]},"article-number":"1474347"}}